[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618557":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":28,"locations":25,"responsibleParty":34,"collaborators":38,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":25,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":62,"whyStopped":25,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":25},{"fullName":5,"class":6},"PAEC General Hospital, Islamabad","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Topical Luliconazole 1% cream","EXPERIMENTAL","Participants will receive topical luliconazole 1% cream applied once daily to affected areas for the treatment of pityriasis versicolor.",[13],"Drug: Luliconazole Cream 1%",{"label":15,"type":10,"description":16,"interventionNames":17},"Topical ketoconazole 2% cream","Participants will receive topical ketoconazole 2% cream applied twice daily to affected areas for the treatment of pityriasis versicolor.",[18],"Drug: Topical ketoconazole 2% cream",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Luliconazole Cream 1%","Ketoconazole is relatively hydrophilic with limited skin retention, whereas luliconazole is highly lipophilic, resulting in superior stratum corneum penetration, higher keratin binding, and prolonged antifungal activity.",[9],null,{"type":21,"name":15,"description":23,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":25,"email":33},"Sana Rafique, MBBS","CONTACT","+923355956563","sanafmdc@gmail.com",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Sana Rafique","Post graduate trainee",[39],{"name":40,"class":41},"PAEC general hospital","OTHER_GOV","100618557","phase-4-comparison-of-the-efficacy-of-topical-luliconazole-2-cream-vs-topical-ketoconazole-1-cream-in-the-treatment-of-pityriasis-versicolor-100618557",false,"NCT07333170","Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.","P versicolor","Inclusion Criteria:\n\n* All patients diagnosed with pityriasis versicolor.\n\nExclusion Criteria:\n\n* Immunocompromised patients","ALL","18 Years","50 Years",{"count":53,"type":54},86,"ESTIMATED","INTERVENTIONAL",[57],"PHASE4","Pityriasis versicolor is a common superficial fungal infection caused by Malassezia species, characterized by hypo- or hyper-pigmented scaly patches on the skin. Topical antifungal agents are the mainstay of treatment. Ketoconazole has been widely used; however, newer agents such as luliconazole may offer improved efficacy and shorter treatment duration. This randomized controlled study aims to compare the efficacy and safety of topical luliconazole versus topical ketoconazole in patients with pityriasis versicolor. Treatment response will be assessed clinically and mycologically to determine comparative outcomes.",[60],"Pityriasis Versicolor",[47],"NOT_YET_RECRUITING","2026-01-09",{"date":65,"type":66},"2026-01-12","ACTUAL",{"date":68,"type":54},"2026-02",{"date":70,"type":54},"2026-11",{"name":5,"class":6}]